budesonide/ formoterol
Showing 1 - 25 of 670
Asthma Trial in Rotterdam (Budesonide/Formoterol fumarate dihydrate)
Recruiting
- Asthma
- Budesonide/Formoterol fumarate dihydrate
-
Rotterdam, Zuid-Holland, NetherlandsFranciscus Gasthuis & Vlietland
Apr 14, 2023
Quality of Life With Administration of Fixed Combination of
Completed
- Asthma
- Quality of Life
- Budesonide/Formoterol treated patients
-
Athens, Mesogion Ave. 152, Greece7th Pulmonary Dept, Athens Chest Hospital
Sep 7, 2022
Asthma Trial in Ruddington (Z7200 without oral activated charcoal, Symbicort Turbohaler without oral activated charcoal, Z7200
Completed
- Asthma
- Z7200 without oral activated charcoal
- +3 more
-
Ruddington, United KingdomQuotient Clinical Ltd
Feb 9, 2022
Asthma Trial in Ruddington (Z7200 without oral activated charcoal, Symbicort Turbohaler without oral activated charcoal, Z7200
Completed
- Asthma
- Z7200 without oral activated charcoal
- +3 more
-
Ruddington, United KingdomQuotient Clinical Ltd
Feb 9, 2022
Healthy Trial in Edmonton (Salbutamol 400mcg, Budesonide/formoterol, Placebo)
Recruiting
- Healthy
- Salbutamol 400mcg
- +2 more
-
Edmonton, Alberta, CanadaClinical Physiology Laboratory
Sep 5, 2023
COPD Trial in Glendale (Treatment A: BGF MDI HFO, Treatment B: BGF MDI HFA)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Treatment A: BGF MDI HFO
- Treatment B: BGF MDI HFA
-
Glendale, CaliforniaResearch Site
Jan 18, 2023
Moderate Asthma Trial in São Paulo (Administration of investigation drug, Administration of comparator)
Not yet recruiting
- Moderate Asthma
- Administration of investigation drug
- Administration of comparator
-
São Paulo, BrazilEurofarma Laboratorios S.A
Feb 9, 2023
Asthma Trial in Porto Alegre, Tatuí, São Paulo (Flamboyant 125/12, Budesonide/formoterol 200/6, Flamboyant 125/12 Placebo)
Recruiting
- Asthma
- Flamboyant 125/12
- +3 more
-
Porto Alegre, Rio Grande Do Sul, Brazil
- +2 more
Jul 25, 2022
COPD Trial in Worldwide (Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate, Treatment B: Budesonide and
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate
- +2 more
-
Torrance, California
- +25 more
Sep 28, 2023
Exercise Induced Asthma Trial in Boston (Budesonide/Formoterol, Budesonide)
Terminated
- Exercise Induced Asthma
-
Boston, Massachusetts
- +1 more
Jul 2, 2021
COPD Trial in Brooklyn (Treatment A (BGF MDI HFO with oral activated charcoal), Treatment B (BGF MDI HFA with oral activated
Recruiting
- Chronic Obstructive Pulmonary Disease
- Treatment A (BGF MDI HFO with oral activated charcoal)
- Treatment B (BGF MDI HFA with oral activated charcoal)
-
Brooklyn, MarylandResearch Site
Aug 11, 2022
Asthma Trial in Medford (Budesonide 80 µg and Formoterol Fumarate Dihydrate 4.5 µg, Symbicort, 80 Mcg-4.5 Mcg/Inh Inhalation
Recruiting
- Asthma
- Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg
- +2 more
-
Medford, OregonVelocity Clinical Research
May 6, 2022
Asthma in Children Trial in France (Budesonide Formoterol Drug Combination, nebulisation of terbutaline)
Recruiting
- Asthma in Children
- Budesonide Formoterol Drug Combination
- nebulisation of terbutaline
-
Boulogne-Billancourt, France
- +7 more
Sep 6, 2021
Asthma in Children, Nonadherence, Medication Trial in Saint Louis (Adherence to symptom driven budesonide/formoterol as compared
Recruiting
- Asthma in Children
- Nonadherence, Medication
- Adherence to symptom driven budesonide/formoterol as compared to adherence to maintenance ICS and symptom-driven SABA
-
Saint Louis, MissouriWashington University in St. Louis School of Medicine
Jan 9, 2023
Real-life After Initation of Treatment With Trixeo
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- BGF (budesonide/glycopyrrolate/formoterol fumarate)
-
Acquaviva delle Fonti, Italy
- +23 more
May 8, 2023
Asthma, Nonadherence, Medication Trial in Saint Louis (Adherence to symptom driven budesonide/formoterol as compared to
Recruiting
- Asthma
- Nonadherence, Medication
- Adherence to symptom driven budesonide/formoterol as compared to adherence to maintenance ICS and symptom-driven SABA
-
Saint Louis, MissouriWashington University in St. Louis School of Medicine
Jan 8, 2023
COPD (COPD) Trial in Guelph (BGF MDI HFO 320/14.4/9.6µg, BGF MDI HFA 320/14.4/9.6 µg, Placebo MDI HFA)
Not yet recruiting
- COPD (Chronic Obstructive Pulmonary Disease)
- BGF MDI HFO 320/14.4/9.6μg
- +2 more
-
Guelph, Ontario, CanadaResearch Site
Oct 4, 2023
Asthma Trial in Tampere (Buventol® Easyhaler® 200 µg/inhalation dmDPI, Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI,
Recruiting
- Asthma
- Buventol® Easyhaler® 200 µg/inhalation dmDPI
- +2 more
-
Tampere, FinlandTampere University Hospital
Oct 26, 2022
Asthma Trial in Tatuí (Flamboyant 200/12, Budesonide / Formoterol 400/12, Flamboyant 200/12 Placebo)
Recruiting
- Asthma
- Flamboyant 200/12
- +3 more
-
Tatuí, São Paulo, BrazilIMC Tatuí
Jul 25, 2022
Symptom and Quality of Life in COPD by
Recruiting
- Pulmonary Disease, Chronic Obstructive
-
Nagoya, Aichi, Japan
- +16 more
Jan 17, 2023
COPD (COPD) Trial in Germany (BFF, Symbicort Turbuhaler)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- BFF
- Symbicort Turbuhaler
-
Frankfurt/Main, Germany
- +3 more
Feb 21, 2022
COPD (COPD) Trial in Glendale (Treatment A, Treatment B, Treatment C)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- Treatment A
- +2 more
-
Glendale, CaliforniaResearch Site
Apr 20, 2022
Asthma Trial in Worldwide (BFF MDI 160/9.6 µg BID (320/19.2µg/day), BD MDI 160 µg BID (320 µg/day))
Recruiting
- Asthma
- BFF MDI 160/9.6 μg BID (320/19.2μg/day)
- BD MDI 160 μg BID (320 μg/day)
-
Huntington Beach, California
- +52 more
Mar 9, 2023
Asthma Trial in United States (Budesonide/Formoterol fumarate dihydrate, Symbicort, Placebo)
Completed
- Asthma
- Budesonide/Formoterol fumarate dihydrate
- +2 more
-
Birmingham, Alabama
- +94 more
Aug 1, 2022